205 related articles for article (PubMed ID: 19693296)
1. Novel null-allele mutations and genotype-phenotype correlation in Argentinean patients with erythropoietic protoporphyria.
Parera VE; Koole RH; Minderman G; Edixhoven A; Rossetti MV; Batlle A; de Rooij FW
Mol Med; 2009; 15(11-12):425-31. PubMed ID: 19693296
[TBL] [Abstract][Full Text] [Related]
2. A Novel Mutation in the FECH Gene in a Czech Family with Erythropoietic Protoporphyria and a Population Study of IVS3-48C Variant Contributing to the Disease.
Farrag MS; Kučerová J; Šlachtová L; Šeda O; Šperl J; Martásek P
Folia Biol (Praha); 2015; 61(6):227-32. PubMed ID: 26789144
[TBL] [Abstract][Full Text] [Related]
3. [Inheritance in erythropoietic protoporphyria].
Schmitt C; Ducamp S; Gouya L; Deybach JC; Puy H
Pathol Biol (Paris); 2010 Oct; 58(5):372-80. PubMed ID: 20850938
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietic protoporphyria.
Lecha M; Puy H; Deybach JC
Orphanet J Rare Dis; 2009 Sep; 4():19. PubMed ID: 19744342
[TBL] [Abstract][Full Text] [Related]
5. Clinical, biochemical, and genetic study of 11 patients with erythropoietic protoporphyria including one with homozygous disease.
Herrero C; To-Figueras J; Badenas C; Méndez M; Serrano P; Enríquez-Salamanca R; Lecha M
Arch Dermatol; 2007 Sep; 143(9):1125-9. PubMed ID: 17875872
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of erythropoietic protoporphyria in South Africa.
Parker M; Corrigall AV; Hift RJ; Meissner PN
Br J Dermatol; 2008 Jul; 159(1):182-91. PubMed ID: 18460026
[TBL] [Abstract][Full Text] [Related]
7. Biochemical abnormality in erythropoietic protoporphyria: cause and consequences.
Bloomer JR; Wang Y; Singhal A; Risheg H
J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S36-40. PubMed ID: 16819399
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity of mutations in the ferrochelatase gene in Italian patients with erythropoietic protoporphyria.
Aurizi C; Schneider-Yin X; Sorge F; Macrì A; Minder EI; Biolcati G
Mol Genet Metab; 2007 Apr; 90(4):402-7. PubMed ID: 17196862
[TBL] [Abstract][Full Text] [Related]
9. Identification of a ferrochelatase mutation in a Chinese family with erythropoietic protoporphyria.
Kong XF; Ye J; Gao DY; Gong QM; Zhang DH; Lu ZM; Lu YM; Zhang XX
J Hepatol; 2008 Feb; 48(2):375-9. PubMed ID: 18160121
[TBL] [Abstract][Full Text] [Related]
10. A novel splicing mutation and haplotype analysis of the FECH gene in a Chinese family with erythropoietic protoporphyria.
Ma J; Xiao S; An J; Wang X; Xu Q; Dong Y; Feng Y; Wang J
J Eur Acad Dermatol Venereol; 2010 Jun; 24(6):726-9. PubMed ID: 19888946
[TBL] [Abstract][Full Text] [Related]
11. The molecular genetics of erythropoietic protoporphyria.
Elder GH; Gouya L; Whatley SD; Puy H; Badminton MN; Deybach JC
Cell Mol Biol (Noisy-le-grand); 2009 Jul; 55(2):118-26. PubMed ID: 19656460
[TBL] [Abstract][Full Text] [Related]
12. Congenital erythropoietic porphyria and erythropoietic protoporphyria: Identification of 7 uroporphyrinogen III synthase and 20 ferrochelatase novel mutations.
Weiss Y; Balwani M; Chen B; Yasuda M; Nazarenko I; Desnick RJ
Mol Genet Metab; 2019 Nov; 128(3):358-362. PubMed ID: 30454868
[TBL] [Abstract][Full Text] [Related]
13. Modeling the ferrochelatase c.315-48C modifier mutation for erythropoietic protoporphyria (EPP) in mice.
Barman-Aksözen J; C Wiek P; Bansode VB; Koentgen F; Trüb J; Pelczar P; Cinelli P; Schneider-Yin X; Schümperli D; Minder EI
Dis Model Mech; 2017 Mar; 10(3):225-233. PubMed ID: 28093505
[TBL] [Abstract][Full Text] [Related]
14. Functional associations of genetic variants involved in the clinical manifestation of erythropoietic protoporphyria in the Argentinean population.
Colombo FP; Rossetti MV; Méndez M; Martínez JE; Enríquez de Salamanca R; del C Batlle AM; Parera VE
J Eur Acad Dermatol Venereol; 2013 Jun; 27(6):754-62. PubMed ID: 22591014
[TBL] [Abstract][Full Text] [Related]
15. Incomplete erythropoietic protoporphyria caused by a splice site modulator homozygous IVS3-48C polymorphism in the ferrochelatase gene.
Mizawa M; Makino T; Nakano H; Sawamura D; Shimizu T
Br J Dermatol; 2016 Jan; 174(1):172-5. PubMed ID: 26280465
[TBL] [Abstract][Full Text] [Related]
16. Co-existence of two functional mutations on the same allele of the human ferrochelatase gene in erythropoietic protoporphyria.
Di Pierro E; Brancaleoni V; Moriondo V; Besana V; Cappellini MD
Clin Genet; 2007 Jan; 71(1):84-8. PubMed ID: 17204051
[TBL] [Abstract][Full Text] [Related]
17. Molecular epidemiology of erythropoietic protoporphyria in the U.K.
Whatley SD; Mason NG; Holme SA; Anstey AV; Elder GH; Badminton MN
Br J Dermatol; 2010 Mar; 162(3):642-6. PubMed ID: 20105171
[TBL] [Abstract][Full Text] [Related]
18. A point mutation affecting an SP1 binding site in the promoter of the ferrochelatase gene impairs gene transcription and causes erythropoietic protoporphyria.
Di Pierro E; Cappellini MD; Mazzucchelli R; Moriondo V; Mologni D; Zanone Poma B; Riva A
Exp Hematol; 2005 May; 33(5):584-91. PubMed ID: 15850836
[TBL] [Abstract][Full Text] [Related]
19. Genotypic determinants of phenotype in North American patients with erythropoietic protoporphyria.
Risheg H; Chen FP; Bloomer JR
Mol Genet Metab; 2003; 80(1-2):196-206. PubMed ID: 14567969
[TBL] [Abstract][Full Text] [Related]
20. Clinical, Biochemical, and Genetic Characterization of North American Patients With Erythropoietic Protoporphyria and X-linked Protoporphyria.
Balwani M; Naik H; Anderson KE; Bissell DM; Bloomer J; Bonkovsky HL; Phillips JD; Overbey JR; Wang B; Singal AK; Liu LU; Desnick RJ
JAMA Dermatol; 2017 Aug; 153(8):789-796. PubMed ID: 28614581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
